A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
Clinical Fellowship/Residency Programs Bookmark and Share

Clinical Fellowships/Residency Programs

City of Hope’s Clinical Fellowship/Residency Programs offer excellent opportunities for physicians interested in expanding their knowledge base and clinical expertise in specialty and subspecialty areas. Our clinical fellowships offer intensive didactic as well as hands-on training by instructors who have made significant contributions to cancer research and clinical practice.
 
 
City of Hope is an SSO accredited program and participates in the SSO match. The mission of our breast surgical oncology training program is to educate future academic and community leaders in breast cancer treatment through sound multidisciplinary and advanced breast surgical training.
 
Director: Laura Kruper, M.D. 
Coordinator: Sharla Moore
 
Growing awareness of the genetic etiology of many types of cancer has driven City of Hope’s National Cancer Institute-designated Comprehensive Cancer Center to offer this innovative program, which provides rigorous interdisciplinary training focused on cancer genetics as well as cancer prevention research.
 
Director: Jeffrey Weitzel, M.D.
Co-Director: Kathleen Blazer, Ed.D., M.S., L.C.G.C.
Coordinator: Arlene Danganan
 
Physicians seeking training in bone marrow transplantation should consider our Hematopoietic Cell Transplant (HCT) Fellowship, which provides extensive training in all aspects of transplantation research and practice. City of Hope is one of the world’s largest and most comprehensive transplant centers.

Director: Amrita Krishnan, M.D.
Coordinator: Margie Miller
 
This fellowship, expanded to City of Hope, offers comprehensive clinical training in diabetes and other endocrine disorders. Fellows are trained in advanced treatment modalities, including City of Hope's innovative islet cell transplantation program.
 
Director: Ken Chiu, M.D.
Coordinator: Karen Ramos
 
This fellowship offers broad-based clinical and research training in hematology and oncology with mentors who are leaders in their field.
 
Director: Marwarn Fakih, M.D. 
Coordinator: Yolanda Tamayo
 
The Hematopathology Fellowship Program at City of Hope is a one-year ACGME accredited fellowship that emphasizes diagnostic neoplastic hematopathology, and is designed for fellows interested in either academic or community practice careers.
 
Director: Joo Song, M.D.
Coordinator: Alejandra Baldrias
 
City of Hope Neurosurgical Oncology Fellowship
The fellowship is a one year program that will offer unique and comprehensive training in the surgical and nonsurgical care of brain and spine tumor patients. Working along with the three neurosurgeons comprising the neurosurgical staff, the fellow will gain a balanced expertise in surgical, clinical and scientific aspects of brain and spinal oncology. Also, there will be exposure to our multidisciplinary team of neurointerventional radiologists and radiation oncologists.

Our goal is to prepare the fellow for a strong career in academic medicine and cultivate not only surgical skills, but also the clinical skills for creating successful surgical outcomes: precise diagnosis, conservative options, palliative care and judgment.
 
Director: Mike Chen, M.D.
Coordinator: Christina Perez
 
City of Hope provides academic instruction for physicians in our Radiation Oncology Residency Program—a four-year Accreditation Council for Graduate Medical Education accredited. The overall goal of the program is to train physicians to be outstanding radiation oncologists and to provide graduates with a solid foundation in translational and clinical research.

Director: Jeffrey Wong, M.D.
Coordinator: Thalia Yaden
 
Even in this age of monoclonal  antibodies and gene therapy, surgical excision is still the standard of care for many solid tumors, while debulking is often helpful in palliative treatment. City of Hope’s Surgical Oncology Fellowship provides two years of thorough surgical oncology training in both clinical and research settings; the fellowship is designed to be tailored to the fellow’s individual interests.
 
Director: Lily Lai, M.D.
Coordinator: Christina Perez
 
The Urology Oncology Fellowship is unique, as it focuses on clinical training in laparoscopic and minimally invasive surgical interventions. These methods are achieving routine status; therefore, it behooves forward-thinking physicians to be well-versed in their practice.
 
Director: Clayton Lau, M.D.
Coordinator: Christina Perez
 

Clinical Fellowship/Residency Programs

Clinical Fellowships/Residency Programs

City of Hope’s Clinical Fellowship/Residency Programs offer excellent opportunities for physicians interested in expanding their knowledge base and clinical expertise in specialty and subspecialty areas. Our clinical fellowships offer intensive didactic as well as hands-on training by instructors who have made significant contributions to cancer research and clinical practice.
 
 
City of Hope is an SSO accredited program and participates in the SSO match. The mission of our breast surgical oncology training program is to educate future academic and community leaders in breast cancer treatment through sound multidisciplinary and advanced breast surgical training.
 
Director: Laura Kruper, M.D. 
Coordinator: Sharla Moore
 
Growing awareness of the genetic etiology of many types of cancer has driven City of Hope’s National Cancer Institute-designated Comprehensive Cancer Center to offer this innovative program, which provides rigorous interdisciplinary training focused on cancer genetics as well as cancer prevention research.
 
Director: Jeffrey Weitzel, M.D.
Co-Director: Kathleen Blazer, Ed.D., M.S., L.C.G.C.
Coordinator: Arlene Danganan
 
Physicians seeking training in bone marrow transplantation should consider our Hematopoietic Cell Transplant (HCT) Fellowship, which provides extensive training in all aspects of transplantation research and practice. City of Hope is one of the world’s largest and most comprehensive transplant centers.

Director: Amrita Krishnan, M.D.
Coordinator: Margie Miller
 
This fellowship, expanded to City of Hope, offers comprehensive clinical training in diabetes and other endocrine disorders. Fellows are trained in advanced treatment modalities, including City of Hope's innovative islet cell transplantation program.
 
Director: Ken Chiu, M.D.
Coordinator: Karen Ramos
 
This fellowship offers broad-based clinical and research training in hematology and oncology with mentors who are leaders in their field.
 
Director: Marwarn Fakih, M.D. 
Coordinator: Yolanda Tamayo
 
The Hematopathology Fellowship Program at City of Hope is a one-year ACGME accredited fellowship that emphasizes diagnostic neoplastic hematopathology, and is designed for fellows interested in either academic or community practice careers.
 
Director: Joo Song, M.D.
Coordinator: Alejandra Baldrias
 
City of Hope Neurosurgical Oncology Fellowship
The fellowship is a one year program that will offer unique and comprehensive training in the surgical and nonsurgical care of brain and spine tumor patients. Working along with the three neurosurgeons comprising the neurosurgical staff, the fellow will gain a balanced expertise in surgical, clinical and scientific aspects of brain and spinal oncology. Also, there will be exposure to our multidisciplinary team of neurointerventional radiologists and radiation oncologists.

Our goal is to prepare the fellow for a strong career in academic medicine and cultivate not only surgical skills, but also the clinical skills for creating successful surgical outcomes: precise diagnosis, conservative options, palliative care and judgment.
 
Director: Mike Chen, M.D.
Coordinator: Christina Perez
 
City of Hope provides academic instruction for physicians in our Radiation Oncology Residency Program—a four-year Accreditation Council for Graduate Medical Education accredited. The overall goal of the program is to train physicians to be outstanding radiation oncologists and to provide graduates with a solid foundation in translational and clinical research.

Director: Jeffrey Wong, M.D.
Coordinator: Thalia Yaden
 
Even in this age of monoclonal  antibodies and gene therapy, surgical excision is still the standard of care for many solid tumors, while debulking is often helpful in palliative treatment. City of Hope’s Surgical Oncology Fellowship provides two years of thorough surgical oncology training in both clinical and research settings; the fellowship is designed to be tailored to the fellow’s individual interests.
 
Director: Lily Lai, M.D.
Coordinator: Christina Perez
 
The Urology Oncology Fellowship is unique, as it focuses on clinical training in laparoscopic and minimally invasive surgical interventions. These methods are achieving routine status; therefore, it behooves forward-thinking physicians to be well-versed in their practice.
 
Director: Clayton Lau, M.D.
Coordinator: Christina Perez
 
Fellowships and Residencies
City of Hope offers a number of exciting fellowships and residencies in laboratory cancer and diabetes research, administration, clinical applications and other areas.

City of Hope is one of only 41 Comprehensive Cancer Centers in the country, the highest designation awarded by the National Cancer Institute to institutions that lead the way in cancer research, treatment, prevention and professional education.
Beckman Research Institute of City of Hope is internationally  recognized for its innovative biomedical research.
Students and professionals at City of Hope can access a plethora of medical databases, scientific journals, course materials, special collections, and other useful resources at our 12,000 square foot Lee Graff Library.
City of Hope has a long-standing commitment to Continuing Medical Education (CME), sharing advances in cancer research and treatment with the health-care community through CME courses such as conferences, symposia and other on and off campus CME opportunities for medical professionals.
Learn more about City of Hope's institutional distinctions, breakthrough innovations and collaborations.


NEWS & UPDATES
  • Few clinical cancer trials include older adults – and yet, more than 60 percent of cancer cases in the United States occur in people age 65 and older. The result is a dearth of knowledge on how to treat the very population most likely to be diagnosed with cancer. Now, the American Society of Clinical […]
  • Scientists at City of Hope and UCLA have become the first to inhibit the expression of a protein, called TWIST that promotes tumor invasion and metastasis when activated by cancer cells. As such, they’ve taken the first step in developing a potential new therapy for some of the deadliest cancers, including ovar...
  • Upon completing her final round of chemotherapy for ovarian cancer earlier this month, Maria Velazquez-McIntyre, a 51-year-old Antelope Valley resident, celebrated the milestone by giving other patients a symbol of hope – a Survivor Bell. The bell may look ordinary, but for cancer patients undergoing chemothera...
  • Many Americans understand that obesity is tied to heart disease and diabetes but, according to a new survey, too few – only 7 percent – know that obesity increases the risk of cancer. Specific biological characteristics can increase cancer risk in obese people, and multiple studies have shown correlations betwe...
  • As breast cancer survivors know, the disease’s impact lingers in ways both big and small long after treatment has ended. A new study suggests that weight gain – and a possible corresponding increase in heart disease and diabetes risk – may be part of that impact. In the first study to evaluate weight chan...
  • Becoming what’s known as an independent scientific researcher is no small task, especially when working to translate research into meaningful health outcomes. Yet that independent status is vital, enabling researchers to lead studies and avenues of inquiry that they believe to be promising. Clinicians, especial...
  • 720 days. That’s how long Alex Tung, 38, had to give up surfing after being diagnosed with acute myeloid leukemia. For most people, even some surfers, such a hiatus wouldn’t be a big deal, but for Tung, surfing has been everything. The Southern California resident began surfing when he was in elemen...
  • There are few among us who have not experienced loss of a friend or loved one, often without warning, or like those of us who care for people with cancer, after a lingering illness. It is a time when emotions run high and deep, and as time passes from the moment of loss, we often […]
  • For the past four years, neurosurgeon and scientist Rahul Jandial, M.D., Ph.D., has been studying how breast cancer cells spread, or metastasize, to the brain, where they become life-threatening tumors. Known as secondary brain tumors, these cancers have become increasingly common as treatment advances have ena...
  • Cutaneous T cell lymphomas are types of non-Hodgkin lymphoma that arise when infection-fighting white blood cells in the lymphatic system – called lymphocytes – become malignant and affect the skin. A primary symptom is a rash that arises initially in areas of the skin that are not normally exposed to sunlight....
  • There’s science camp, and then there’s “mystery” science camp. City of Hope’s new science camp for middle school students is of the especially engaging latter variety. From Monday, July 13, to Friday, July 17, rising middle-school students from across the San Gabriel Valley were presented with a “patient” with ...
  • Women diagnosed with breast cancer quickly learn their tumor’s type, meaning the characteristics that fuel its growth. That label guides the treatment of their disease, as well as their prognosis when it comes to treatment effectiveness. Sometimes, however, doctors can’t accurately predict treatment effectivene...
  • In years past, Bladder Cancer Awareness Month has been a sobering reminder of a disease with few treatment options. For patients with metastatic disease (disease that has spread from the bladder to distant organs), average survival is typically just over one year. Fortunately, things are changing. Academic inst...
  • Tina Wang was diagnosed with Stage 4 diffuse large b cell lymphoma at age 22. She first sought treatment at her local hospital, undergoing two cycles of treatment. When the treatment failed to eradicate her cancer, she came to City of Hope. Here, Wang underwent an autologous stem cell transplant and participate...
  • When Gilbert Fresquez, 72, lost an excessive amount of weight in late 2012, he didn’t think much of it. He assumed it was a side effect from a recent surgery to remove a carcinoid tumor in his small intestine. It wasn’t until a couple of years later during a routine doctor’s visit that the retired […]